ENCRETA Trademark

Trademark Overview

On Saturday, August 27, 2016, a trademark application was filed for ENCRETA with the United States Patent and Trademark Office. The USPTO has given the ENCRETA trademark a serial number of 79195698. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 15, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The ENCRETA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
encreta

General Information

Serial Number79195698
Word MarkENCRETA
Filing DateSaturday, August 27, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 15, 2023
Registration Number5211413
Registration DateTuesday, May 30, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Thursday, November 10, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, January 16, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 15, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, November 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 22, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, December 7, 2016ASSIGNED TO EXAMINER
Thursday, December 8, 2016NON-FINAL ACTION WRITTEN
Friday, December 9, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 12, 2016REFUSAL PROCESSED BY MPU
Monday, December 12, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 30, 2016REFUSAL PROCESSED BY IB
Wednesday, February 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 14, 2017PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Friday, June 9, 2017NOTIFICATION PROCESSED BY IB
Thursday, February 2, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 2, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 3, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 3, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 4, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 6, 2017FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 30, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 15, 2023CANCELLED SECTION 71
Friday, August 16, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, August 28, 2024INVALIDATION PROCESSED
Friday, July 28, 2017LIMITATION OF GOODS RECEIVED FROM IB
Thursday, August 3, 2017LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Wednesday, September 6, 2017FINAL DISPOSITION PROCESSED
Saturday, October 21, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, September 14, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, August 28, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords

encreta system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary